Circassia Ltd.

ACTIVE

United Kingdomwww.circassia.comPublic51–100 employeesEstablished: 2006-01-01

Part of Niox Group Plc

Clinical Trials

7 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2006

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

62.5%

Not Applicable

12.5%

Phase 2

12.5%

Trial Status Distribution

Active, not recruiting

75.0%

Completed

12.5%

Not yet recruiting

12.5%

Clinical Trials

Trials sponsored by this organization (8)

Systemic exposure study between orally inhaled fluticasone propionate and salmeterol (as xinafoate) delivered via two different pMDIs

Not Applicable

Completed

interventional

Oct 201730 participants

A study to investigate the effectiveness and safety of HDM-SPIRE in people allergic to House Dust Mite

Phase 1

Active, not recruiting

Sep 2015660 participants

A study to investigate the effectiveness and safety of HDM-SPIRE in people allergic to House Dust Mite

Phase 1

Active, not recruiting

Sep 2015660 participants

A study to investigate the effectiveness and safety of HDM-SPIRE in people allergic to House Dust Mite

Phase 1

Active, not recruiting

Sep 2014660 participants

A study to investigate the effectiveness and safety of HDM-SPIRE in people allergic to House Dust Mite

Phase 1

Active, not recruiting

Sep 2014660 participants

A study to investigate the effectiveness and safety of HDM-SPIRE in people allergic to House Dust Mite

Phase 1

Active, not recruiting

Jul 2014660 participants

An Escalating Single Intradermal or Subcutaneous Dose Study in Cat Allergic Subjects to Assess the Safety of Cat-PAD

Active, not recruiting

Jun 2007

A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects with a History of House Dust Mite-Induced Rhinoconjunctivitis

Approvals

No approval data available

News

No news articles found

Back to Organizations